[1]
Abbas, M. et al. 2026. Andembry (Garadacimab-gxii): A Novel Monoclonal Antibody for Preventing Hereditary Angioedema Attacks. Journal of Community Medicine and Health Solutions. (May 2026), 55–58. DOI:https://doi.org/10.29328/journal.jcmhs.1001073.